Search for Clinical Trial Results

Sponsored By

Pseudomonas Infections - 25 Studies Found

Status Study
Terminated Study Name: Lcr35 / ICU / P. Aeruginosa
Condition: Pseudomonas Infections
Date: 2008-02-11
Interventions: Drug: Probiotic Lactobacillus casei rhamnosus (Lcr35)
Completed Study Name: Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects
Condition: Pseudomonas Aeruginosa
Date: 2016-02-11
Interventions:
  • Drug: MEDI3902 Active
Completed Study Name: Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects
Condition: Pseudomonas Infection
Date: 2014-06-26
Interventions:
  • Drug: Fosfomycin tromethamine

Terminated Study Name: Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia
Condition:
  • Pneumonia, Ventilator-Associated
  • Pseudomonas Infections
    • Date: 2008-01-24
    Interventions:
    • Drug: azithromycin 300 mg/day,
Completed Study Name: Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa
Condition: Pseudomonas Aeruginosa Infection
Date: 2011-05-16
Interventions:
  • Drug: Piperacillin-Tazobactam continuous infusion

Recruiting Study Name: Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Condition:
  • Pseudomonas Infection
  • Cystic Fibrosis

Date: 2001-11-27
Completed Study Name: The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
Condition:
  • Pseudomonas Aeruginosa
  • Cystic Fibrosis

Date: 2012-01-09
Completed Study Name: Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
Condition:
  • Cystic Fibrosis
  • Pseudomonas Aeruginosa

Date: 2008-10-16
Interventions: Drug: Tobramycin (Gernebcin®) 1 ml / day in each nostril
Completed Study Name: Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
Condition: Pseudomonas Aeruginosa Infection
Date: 2012-03-14
Interventions:
  • Biological: IC43 100 mcg
Completed Study Name: Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN)
Condition:
  • Pseudomonas Aeruginosa
  • Ventilation Acquired Pneumonia
    • Date: 2012-10-08
Next >>>